NVCR Q2 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$134M+15.2% YoY

Gross Profit

$105M78.6% margin

Operating Income

-$12M-9.2% margin

Net Income

-$15M-11.0% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$24M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$700M

Stockholders' Equity

$397M

Cash & Equivalents

$349M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$116M	+15.2%
Gross Profit	$105M	$90M	+16.0%
Operating Income	-$12M	$7M	-284.4%
Net Income	-$15M	$2M	-984.7%

Geographic Segments

UNITED STATES

$87M65%

GERMANY

$25M19%

JAPAN

$9M7%

EMEA, Exculding Germany

$7M5%

CHINA

$5M4%